Navigation Links
Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
Date:7/2/2008

- Top-line Data Expected in August -

EXTON, Pa., July 2 /PRNewswire-FirstCall/ -- Isolagen(TM), Inc. (Amex: ILE) announced today the completion of the pivotal efficacy portion of its Phase III clinical studies (IT-R-005/006) investigating the Isolagen Therapy(TM) for the treatment of nasolabial folds, or wrinkles. The last person in each study has completed the primary efficacy follow-up visit, and collation of this data has begun. The Company anticipates that top-line efficacy and safety data analyses from the studies will be reported in August 2008.

"The completion of the pivotal efficacy portion of our Phase III clinical studies is a major milestone for Isolagen," said Declan Daly, Chief Executive Officer of Isolagen. "I commend the Isolagen team and our investigators for their efforts and look forward to announcing the data once it is un-blinded later this summer."

About the Isolagen Process(TM) and Isolagen Therapy(TM)

The Isolagen Process(TM) is an innovative cellular processing system which creates a natural, living cell therapy. By multiplying a patient's own collagen-producing cells or fibroblasts into tens of millions of new cells, a personalized treatment is created which is then returned to the patient's skin. This treatment, known as the Isolagen Therapy, is designed to improve skin damage caused by the normal effects of aging, sun damage, acne and burns.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic company committed to developing and commercializing scientific advances and innovative technologies. The company's technology platform includes the Isolagen Process(TM), a cell processing system for skin and tissue rejuvenation which is
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
2. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
6. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
9. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013  Millennium HealthCare Inc. (OTC ... into an exclusive 25-year Supply and Distribution agreement ... Corporation ("EWC") for its Distance Monitored Physical Therapy ... physical therapy program is a critical element in ... said Chris Amandola , president, Millennium HealthCare ...
(Date:6/18/2013)... , June 18, 2013  Specialty ... significant breakthrough in Parylene coating technologies: SCS ... the benefits of Parylene with antimicrobial properties ... devices and components. (Logo: ... infections (HAIs) increase and continue to pose ...
(Date:6/18/2013)... MPR is excited to unveil a new logo and ... of an ongoing effort to freshen the look and feel ... years. (Photo: http://photos.prnewswire.com/prnh/20130618/NY33937 ) ... has expanded upon its foundation as a concise drug information ... array of clinical and practice management tools including a cloud-based ...
Breaking Medicine Technology:Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 2Millennium HealthCare Signs Exclusive Distribution Agreement with eWellness Corporation for Northeast and Mid-Atlantic Regions 3Specialty Coating Systems Announces New Antimicrobial Parylene Technology 2MPR Sports a Bold New Look 2
... The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine ... as its July 2010 "Stock to Study" and Gilead ... for investors, informational and educational use. , ... "The committee chose Teva Pharmaceutical Industries because of the tremendous ...
... EAST BRUNSWICK, N.J. , April 30 Savient Pharmaceuticals, Inc. (Nasdaq: ... the first quarter 2010 following the close of the market on Wednesday ... , ... Financial Officer, will host an investment community conference call beginning at 10:00 ...
Cached Medicine Technology:BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 2BetterInvesting Magazine Releases July's Stock to Study and Undervalued Stock Choices for Investors' Informational and Educational Use 3Savient Pharmaceuticals To Hold First Quarter 2010 Results 2
(Date:6/18/2013)... Park City, UT (PRWEB) June 18, 2013 ... employees on Health Reimbursement Accounts . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, employees of a ... Account (HRA) may have questions about how Health Reimbursement ...
(Date:6/18/2013)... 18, 2013 New York magazine named 145 ... its “Best Doctors” list, up from 129 last year and ... new issue also lists 52 additional doctors who serve at ... strategic growth trajectory. The “Best Doctors” issue, which this year ... 24 print issue and is available online at http://www.nymag.com/bestdoctors ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... declared June as Lesbian, Gay, Bisexual and ... in civil rights, sexual minority youth are ... their heterosexual peers, according to the Suicide ... psychology graduate student recently published recommendation to ... which could help improve psychological functioning and ...
(Date:6/18/2013)... 18, 2013)-- An international team of investigators co-led by ... for evidence-based surgery and device research, similar to the ... medicine. , "Currently, there is no dynamic research framework ... any benefits to patients or may even be harmful," ... Medical College. , In the June 18 issue ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Health Reimbursement Accounts 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 2Health News:Mount Sinai Tops the List in New York Magazine’s 2013 “Best Doctors” Issue 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Sexual minority youth need specialized treatment from therapists 2Health News:Tackling a framework for surgical innovation 2Health News:Tackling a framework for surgical innovation 3
... published in the Journal of Vascular Surgery reported that ... better// when accompanied by a suction device to remove ... kidneys. ,Researchers from the Wake Forest University ... that short, less invasive procedures restored enough blood flow ...
... now investigating Dr Wakefield over claims of serious professional misconduct//. ... Wakefield and subsequently published in The Lancet in 1998, had ... might exist a causal link between the combined measles, mumps ... ,Reports now indicate that the GMC is now charging ...
... The death of a 65-year-old woman at the ... Ms Hannah Comber died //from asphyxiation after she ... special chair.,The HSE said, it is fully co-operating ... into the incident at a continuing care facility ...
... have found that astemizole, which is used for treating ... for treating malaria//. ,According to a study conducted ... Public Health and the Johns Hopkins University School of ... Malaria Research Institute (MRI), determined that in a test ...
... the urology segment, pharma major Dr Reddys Laboratories Ltd ... release tablets of 10 mg dosage. ... indicated for treatment of enlargement of prostate gland in ... company release said., ,The product was launched nationwide, ...
... volunteers have found that external ‘condom’ catheter showed lesser ... ,An 80 per cent reduction in urinary ... was collected with condom type catheter, which proved a ... ,In fact, men whose urine was collected with an ...
Cached Medicine News:Health News:Blood Flow to Kidneys Better Restored by Less Invasive Procedures 2Health News:Antihistamine Could also be used as a Potential Antimalarial Drug 2Health News:External Catheters Linked with decreased UTI Risk in Men 2Health News:External Catheters Linked with decreased UTI Risk in Men 3Health News:External Catheters Linked with decreased UTI Risk in Men 4
... GORE SEAMGUARD® Bioabsorbable Staple Line ... procedures in which soft tissue transection ... is needed.,The GORE SEAMGUARD Bioabsorbable Staple ... easy-to-use material for reinforcement of staple ...
... for temporary wound support. Especially suitable ... stretchable support material is desired and ... required. Predictable absorption. Polyglactin 910 has ... and nonpyrogenic. ,VICRYL (polyglactin 910) knitted ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
... Biosurgical Composite is designed for the repair ... PPM mesh that has two distinct sides. ... coated with a layer of sodium hyaluronate ... Adhesion Barrier). This coated side is bioresorbable, ...
Medicine Products: